Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P3WF
|
||||
Former ID |
DIB019106
|
||||
Drug Name |
CGP 23996
|
||||
Synonyms |
CGP23996; CGP-23996
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539290] | ||
Structure |
Download2D MOL |
||||
Formula |
C73H99N15O18
|
||||
InChI |
InChI=1S/C73H99N15O18/c1-41(90)61-71(103)85-55(36-45-28-30-47(92)31-29-45)69(101)88-62(42(2)91)72(104)86-58(40-89)70(102)80-52(73(105)106)26-10-5-11-27-60(94)78-50(24-14-16-32-74)63(95)84-57(38-59(76)93)68(100)82-53(34-43-18-6-3-7-19-43)65(97)81-54(35-44-20-8-4-9-21-44)66(98)83-56(37-46-39-77-49-23-13-12-22-48(46)49)67(99)79-51(64(96)87-61)25-15-17-33-75/h3-4,6-9,12-13,18-23,28-31,39,41-42,50-58,61-62,77,89-92H,5,10-11,14-17,24-27,32-38,40,74-75H2,1-2H3,(H2,76,93)(H,78,94)(H,79,99)(H,80,102)(H,81,97)(H,82,100)(H,83,98)(H,84,95)(H,85,103)(H,86,104)(H,87,96)(H,88,101)(H,105,106)/t41-,42-,50+,51+,52+,53+,54+,55+,56+,57?,58+,61?,62?/m1/s1
|
||||
InChIKey |
HTEPNQQGQXAYEW-YQENAMKYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Somatostatin receptor type 2 | Target Info | Agonist | [534665] | |
Somatostatin receptor type 4 | Target Info | Agonist | [525652] | ||
Somatostatin receptor 1 | Target Info | Agonist | [525652] | ||
Somatostatin receptor type 3 | Target Info | Agonist | [525652] | ||
Somatostatin receptor type 5 | Target Info | Agonist | [534665] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
PathWhiz Pathway | Gastric Acid Production | ||||
WikiPathways | SIDS Susceptibility Pathways | ||||
GPCRs, Class A Rhodopsin-like | |||||
Peptide GPCRs | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP455:GPCRs, Class A Rhodopsin-like | |||||
GPCR downstream signalingWP706:SIDS Susceptibility Pathways | |||||
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.